Option chain shows key data for StageZero Life Sciences's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for StageZero Life Sciences.

StageZero Life Sciences (OTC:SZLSF) Stock, Option Chain

StageZero Life Sciences Ltd is a vertically integrated healthcare company at the nexus of three sectors of healthcare; Early Cancer Detection, Liquid Biopsy, and Global Telehealth. It is focused on minimizing the risk of cancer and other chronic diseases through early detection and intervention. It continues to develop and commercialize proprietary molecular diagnostic tests for the early detection of diseases and personalized health management, with a focus on cancer-related indications. It has developed a proprietary platform technology, the Sentinel Principle, to identify novel biomarkers from whole blood. The Company's lead product, Aristotle, is a blood-based molecular diagnostic assessment that can detect an individual's current risk for potentially having a variety of cancers.

News

Penny Stocks

STAGEZERO LIFE SCIENCES by Stagezero Life Sciences Ltd.

SZLSF

TSX:SZLS

StageZero Life Sciences, Ltd. (TSX: SZLS) (OTCQB: SZLSF) 

StageZero Life Sciences Partners With DiagnoseAtHome To Offer Multi-Cancer Blood Test

Comments

StageZero Life Sciences

StageZero Life Sciences (SZLSF) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell